What this test evaluates Blood concentration of CEA (ng/mL) Tumor-related antigen activity, particularly from gastrointestinal sources Why a CEA test is ordered Baseline and follow-up monitoring in people with a history of colorectal cancer Detection of recurrence or progression after surgery, chemotherapy, or radiation Assessment of treatment response Supportive evaluation when symptoms or imaging raise concern for malignancy How CEA levels are interpreted CEA is not cancer-specific Elevated levels can be seen with: Colorectal cancer Other cancers (gastric, pancreatic, lung, breast) Smoking Inflammatory bowel disease Liver disease Pancreatitis or infection For this reason, CEA is not used as a screening test in healthy individuals What results may show Low or stable CEA: generally reassuring, especially when consistent over time Rising CEA trend: may suggest recurrence or active disease and usually prompts further evaluation Isolated mild elevation: often nonspecific

Three cycles in now, and the changes have been gradual but real
According to the American Stroke Association, stroke is one of the top causes of disability in the United States and the fifth-leading cause of death
What you should take away as a patient: peptide therapy can still be pursued legitimately in 2026, but it requires a clinic that tracks the current regulatory position, sources through licensed pharmacies, and is honest about what is and is not settled